Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen Morrisroe

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Current Opinion in Rheumatology|October 1, 2020
Cancer and scleroderma: recent insightsKathleen Morrisroe, Mandana Nikpour
The Lancet. Rheumatology|May 17, 2025
Why is progressive ILD in systemic sclerosis so difficult to predict?Kathleen Morrisroe, Murray Barron
Rheumatology (Oxford, England)|July 31, 2015
Drug-induced hypereosinophilia related to tocilizumab therapy for rheumatoid arthritisKathleen Morrisroe, Melinda Wong
European Respiratory Review : an Official Journal of the European Respiratory Society|January 14, 2026
Associations with, and predictors of, progression in systemic sclerosis-related interstitial lung disease: a scoping literature reviewKathleen Morrisroe, Murray Baron
Arthritis Research & Therapy|April 14, 2026
Proportions of patients meeting definitions for progressive disease or improvement should be included in clinical trials for systemic sclerosis interstitial lung diseaseKathleen Morrisroe, Donald Tashkin, Murray Baron
Rheumatic Diseases Clinics of North America|April 7, 2023
Health Care Utilization: What Is the Cost of Caring for Scleroderma?Kathleen Morrisroe, Nora Sandorfi, Murray Barron
Family Practice|September 1, 2022
To use or not to use buprenorphine for illegally manufactured fentanylLakshit Jain, Kathleen Morrisroe, Vania Modesto-Lowe
Journal of Pediatric Surgery|November 17, 2022
Gertrude Herzfeld: The woman who dared to be a surgeonKathleen Morrisroe, Don K Nakayama, Katerina Dukleska
Journal of Scleroderma and Related Disorders|April 6, 2022
Small intestinal bacterial overgrowth in systemic sclerosisKathleen Morrisroe, Murray Baron, Tracy Frech, et al.
International Journal of Rheumatic Diseases|October 28, 2017
A systematic review of the epidemiology, disease characteristics and management of systemic sclerosis in Australian adultsKathleen Morrisroe, Wendy Stevens, Susanna Proudman, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Current Opinion in Rheumatology|October 1, 2020
Cancer and scleroderma: recent insightsKathleen Morrisroe, Mandana Nikpour
The Lancet. Rheumatology|May 17, 2025
Why is progressive ILD in systemic sclerosis so difficult to predict?Kathleen Morrisroe, Murray Barron
Rheumatology (Oxford, England)|July 31, 2015
Drug-induced hypereosinophilia related to tocilizumab therapy for rheumatoid arthritisKathleen Morrisroe, Melinda Wong
European Respiratory Review : an Official Journal of the European Respiratory Society|January 14, 2026
Associations with, and predictors of, progression in systemic sclerosis-related interstitial lung disease: a scoping literature reviewKathleen Morrisroe, Murray Baron
Arthritis Research & Therapy|April 14, 2026
Proportions of patients meeting definitions for progressive disease or improvement should be included in clinical trials for systemic sclerosis interstitial lung diseaseKathleen Morrisroe, Donald Tashkin, Murray Baron
Rheumatic Diseases Clinics of North America|April 7, 2023
Health Care Utilization: What Is the Cost of Caring for Scleroderma?Kathleen Morrisroe, Nora Sandorfi, Murray Barron
Family Practice|September 1, 2022
To use or not to use buprenorphine for illegally manufactured fentanylLakshit Jain, Kathleen Morrisroe, Vania Modesto-Lowe
Journal of Pediatric Surgery|November 17, 2022
Gertrude Herzfeld: The woman who dared to be a surgeonKathleen Morrisroe, Don K Nakayama, Katerina Dukleska
Journal of Scleroderma and Related Disorders|April 6, 2022
Small intestinal bacterial overgrowth in systemic sclerosisKathleen Morrisroe, Murray Baron, Tracy Frech, et al.
International Journal of Rheumatic Diseases|October 28, 2017
A systematic review of the epidemiology, disease characteristics and management of systemic sclerosis in Australian adultsKathleen Morrisroe, Wendy Stevens, Susanna Proudman, et al.
Pageof 7